Oral Health Linked to Pain Levels in Women, Study Finds
A recent study published on April 9 in Frontiers in Pain Research highlights a significant correlation between oral health and pain, particularly migraine headaches, among women. Conducted by Sharon Erdrich and her research team from The University of Sydney, the study sheds light on the intricate relationship between oral health, the oral microbiome, and various manifestations of bodily pain.
Methodology Overview
The researchers utilized the World Health Organization oral health questionnaire to evaluate the oral health of participants. Additionally, validated tools were employed to assess different types of pain, including bodily pain, migraine, and abdominal discomfort.
Key Findings
- Women with the lowest oral health scores showed a higher propensity for experiencing migraine headaches and elevated body pain scores.
- After accounting for potential confounding variables, four bacterial species were notably linked to elevated bodily pain levels as measured by the Short Form-36 bodily pain scale.
- A moderate relationship was identified between the abundance of Gardnerella and oral health scores, while associations with migraine headaches were particularly noted for the genera Lancefieldella and Mycoplasma salivarius.
The authors concluded that “lower oral health scores and higher abundance of a range of oral pathobionts to be associated with higher pain scores,” suggesting that the oral microbiome may play a role in pain signaling. They advocate for further research to explore the potential connection between the oral microbiome and the nervous system’s pain response.
Study Implications
This research underscores the importance of oral health as not only a matter of hygiene but potentially as a factor in overall health and pain management, particularly in women. The implications of these findings suggest that healthcare providers may need to consider the oral microbiome when addressing pain-related conditions.
Note: Two authors have disclosed affiliations with Viome Life Sciences.
